PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
Desoximetasone Topical Spray | 0.25% |
100 mL |
68180-944-33 |
Topicort® Topical Spray |
AT |
Corticosteroid |
|
Desvenlafaxine Extended-Release Tablets | 25mg |
30 |
68180-592-06 |
Pristiq® |
AB |
Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) |
|
Diazepam Rectal Gel | 10 mg & 20 mg |
4.4 cm & 6.0 cm |
43386-281-01 |
||||
Diclofenac Sodium Topical Solution | 2% |
112g |
68180-537-01 |
Pennsaid® 2% |
AB |
Topical nonsteroidal anti-inflammatory drug (NSAID) |
|
Doxycycline Monohydrate Capsules USP | 50mg |
50 |
68180-650-01 |
Monodox® |
AB |
Anti-Infectives |
|
Fenofibrate Capsules | 90mg |
30 |
68180-746-06 |
Antara® |
AB |
Antihyperlipidemic |
|
Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
|
Ganirelix Acetate Injection | 250mcg/0.5mL |
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
|
Ibuprofen and Famotidine Tablets | 800mg/ 26.6mg |
90 |
70748-312-09 |
Duexis® |
AB |
NSaID |
|
Lurasidone Hydrochloride Tablets | 20mg |
30 |
68180-670-06 |
Latuda® |
AB |
Atypical antipsychotics |
|
Merzee® (norethindrone acetate and ethinyl estradiol and ferrous fumarate capsules) | 1 mg/20 mcg |
28 |
43386-371-32 |
Taytulla® |
AB |
Oral Contraceptives |
|
Moxifloxacin Ophthalmic Solution USP | 0.5% |
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.